Início › Colite ulcerativa › Texas › San Antonio
Ensaios clínicos de Colite ulcerativa em San Antonio, TX
16 estudos para Colite ulcerativa estão buscando participantes em locais em San Antonio e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RecrutandoFase 3
- Southern Star Research Institute ( Site 0299), San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecrutandoFase 2
- Southern Star Research Institute /ID# 280822, San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
RecrutandoFase 2
- Southern Star Research Institute, San Antonio
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RecrutandoFase 2
- Gastroenterology Research of San Antonio, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
- Xencor Investigative Site, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RecrutandoFase 2
- Site 002, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
RecrutandoFase 3
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RecrutandoFase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RecrutandoFase 2
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RecrutandoFase 2
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RecrutandoFase 2
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
RecrutandoFase 4
- Gastroenterology Research of San Antonio, LLC, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RecrutandoFase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
RecrutandoFase 3
- Southern Star Research Institute, LLC, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RecrutandoFase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
RecrutandoEstudo observacional
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
Ensaios de Colite ulcerativa em outras cidades
- New York City, NY23 estudos
- Orlando, FL22 estudos
- Miami, FL21 estudos
- Houston, TX17 estudos
- Tacoma, WA15 estudos
- Chicago, IL15 estudos
- San Diego, CA15 estudos
- Tyler, TX14 estudos
- Colorado Springs, CO14 estudos
- Los Angeles, CA13 estudos
- St. Louis, MO13 estudos
- Washington, DC12 estudos
Outros estudos em San Antonio
- Câncer de Pulmão de Não Pequenas Células59 estudos
- Câncer Colorretal46 estudos
- Câncer de Mama46 estudos
- Câncer Metastático44 estudos
- Câncer (todos os tipos)41 estudos
- Obesidade40 estudos
- Diabetes tipo 237 estudos
- Sobrepeso34 estudos
- Câncer de Ovário31 estudos
- Câncer de Pâncreas31 estudos
- Câncer de Próstata28 estudos
- Câncer Endometrial27 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.